AT2030 Venture Spotlight Series featuring SynPhNe

AT2030 Venture spotlight series

This AT2030 Spotlight Series profiles growth-stage assistive technology businesses developing practical technologies and business models to meet unmet access needs at scale. Each case study explores the problem they are addressing, the model they are building, the evidence behind their work, and how AT2030, GDI Hub and GDI Accelerate are supporting their growth trajectory.

SynPhNe

SynPhNe is a neurological rehabilitation company developing technology to deliver high-intensity, personalised therapy for stroke and other neurological conditions. Founded in Singapore and extending to the US and India markets, the company has built a platform that captures brain and muscle signals in real time to guide recovery. Their work focuses on extending effective rehabilitation beyond specialist clinical settings, enabling structured, data-driven therapy in both clinics and home environments.